A high resolution ultrastructural study of experimental murine AA amyloid

Laboratory Investigation

Volumn 74, Issue 3, 1996, Pages 670-683

  Inoue, Sadayuki ^a   Kisilevsky, Robert ^b  

^a MCGILL UNIVERSITY   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; AMYLOID A PROTEIN; AMYLOID P COMPONENT; ANTISERUM; PROTEOCHONDROITIN SULFATE; PROTEOHEPARAN SULFATE;

AMYLOIDOSIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; FIBER; IMMUNOGOLD STAINING; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; ULTRASTRUCTURE;

AMYLOIDOSIS; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; HEPARAN SULFATE PROTEOGLYCANS; HEPARITIN SULFATE; MICE; MICROSCOPY, ELECTRON; MICROSCOPY, IMMUNOELECTRON; PROTEOCHONDROITIN SULFATES; PROTEOGLYCANS; RABBITS; SERUM AMYLOID A PROTEIN; SERUM AMYLOID P-COMPONENT; SPLENIC DISEASES;

EID: 0029868555     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Brissette L, Young I, Narindrasorasak S, Kisilevsky R, and Deeley R (1989). Differential induction of the serum amyloid-A gene family in response to an inflammatory agent and to amyloid-enhancing factor. J Biol Chem 264:19327-19332.
2. Cohen AS (1965). The constitution and genesis of amyloid. Int Rev Exp Pathol 4:159-243.
3. Cohen AS (1968). High resolution ultrastructure, immunology, and biochemistry of amyloid. In: Mandema E, Ruinen L, Scholten JH, and Cohen AS, editors. Proceedings of the Symposium of Amyloidosis, University of Groningen, The Netherlands. Amsterdam: Excerpta Medica Foundation, 147.
4. Cohen AS and Calkins E (1959). Electron microscopic observations on a fibrous component in amyloid of diverse origins. Nature 183:1202-1203.
5. Cohen AS, Shirahama T, and Skinner M (1982). Electron microscopy of amyloid. In: Harris JR, editor. Electron microscopy of proteins. London: Academic Press, 165.
6. Coria F, Castano E, Prelli F, Larrondo-Lillo M, Van Duinen S, Shelanski ML, and Frangione B (1988). Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis. Lab Invest 58:454-458.
7. Eldred WD, Zucker C, Karten HJ, and Yazulla S (1983). Comparison of fixation and penetration enhancement techniques for use in ultrastructural immunocytochemistry. J Histochem Cytochem 31:285-292.
8. Ghidoni JJ and Gueft B (1962). The double nature of the amyloid fiber. In: Breezze SS Jr, editor. Electron microscopy: Fifth International Congress for Electron Microscopy, part 2. New York: Academic Press, 1-15.
9. Glenner GG and Page DL (1976). Amyloid, amyloidosis, and amyloidogenesis. Int Rev Exp Pathol 15:1-92.
10. Gueft B and Ghidoni JJ (1963). The site of formation and ultrastructure of amyloid. Am J Pathol 43:837-854.
11. Gueft B, Kikkawa Y, and Hirschl S (1968). An electron-microscopic study of amyloidosis from different species. In: Mandema E, Ruinen L, Schotten JH, and Cohen AS, editors. Proceedings of the Symposium of Amyloidosis, University of Groningen, The Netherlands. Amsterdam: Excerpta Medica Foundation, 172.
12. Holck M, Husby G, Sletten K, and Natvig JB (1979). The amyloid P component (protein AP): An integral part of the amyloid substance? Scand J Immunol 10:55-60.
13. Inoue S (1991). Pentosome - a new connective tissue component - is a subunit of amyloid P. Cell Tissue Res 263:431-438.
14. Inoue S (1995a). Ultrastructural organization of connective tissue microfibrils in the posterior chamber of the eye both in vivo and in vitro. Cell Tissue Res 279:291-302.
15. Inoue S (1995b). Ultrastructural and immunohistochemical studies of microfibril-associated components in the posterior chamber of the eye. Cell Tissue Res 279:303-313.
16. Inoue S, Grant D, and Leblond CP (1989). Heparan sulfate proteoglycan is present in basement membranes as a double-tracked structure. J Histochem Cytochem 37:597-602.
17. Inoue S and Leblond CP (1986). The microfibrils of connective tissue. I. Ultrastructure. Am J Anat 176:121-138.
18. Kisilevsky R (1990). Heparan sulfate proteoglycans in amyloidogenesis: An epiphenomenon, a unique factor, or the tip of a more fundamental process? Lab Invest 63:589-591.
19. Kisilevsky R, Narindrasorasak S, Tape C, Tan R, and Boudreau L (1994). During AA amyloidosis is proteolytic attack on serum amyloid A a pre- or post-fibrillogenic event? Amyloid Int J Exp Clin Invest 1:174-183.
20. Laurie GW (1985). Lack of heparan sulfate proteoglycan in a discontinuous and irregular placental basement membrane. Dev Biol 108:299-309.
21. Laurie GW, Leblond CP, Inoue S, Martin GR, and Chung A (1984). Fine structure of the glomerular basement membrane and immunolocalization of five basement membrane components to the lamina densa (basal lamina) and its extensions in both glomeruli and tubules of the rat kidney. Am J Anat 169:463-481.
22. Magnus JH, Husby G, and Kolset SO (1989). Presence of glycosaminoglycans in purified AA type amyloid fibrils associated with juvenile rheumatoid arthritis. Ann Rheum Dis 48:215-219.
23. Magnus JH, Kolset SO, and Husby G (1991a). High molecular weight glycosaminoglycans in AA-type amyloid fibril extracts from human liver. Ann Rheum Dis 50:562-526.
24. Magnus JH, Stenstad T, Husby G, and Kolset SO (1992). Isolation and partial characterization of heparan sulfate proteoglycans from human hepatic amyloid. Biochem J 288: 225-231.
25. Magnus JH, Stenstad T, Kolset SO, and Husby G (1991b). Glycosaminoglycans in extracts of cardiac amyloid cardiomyopathy of Danish origin related to variant transthyretin MET-111. Scand J Immunol 34:63-69.
26. Miyakawa T, Katsuragi S, and Kuramoto R (1988). Ultrastructure of perivascular amyloid fibrils in Alzheimer's disease. Virchows Arch Cell Pathol 56:21-24.
27. Miyakawa T, Katsuragi S, Watanabe K, Shimoji A, and Ikeuchi Y (1986). Ultrastructural studies of amyloid fibrils and senile plaques in human brain. Acta Neuropathol 70:202-208.
28. Miyakawa T, Katsuragi S, and Watanabe K (1990). Ultrastructure of amyloid fibrils in Alzheimer's disease and Down's syndrome. In: Isobe T, Araki S, Uchino F, Kato S, and Tsubura E, editors. Amyloid and amyloidosis: Proceedings of 5th International Symposium on Amyloidosis, Hakone, Japan. New York: Plenum Press, 573.
29. Nelson SR, Lyon M, Gallagher JT, Johnson EA, and Pepys MB (1991). Isolation and characterization of the integral glycosaminoglycan constituents of human amyloid-A and monoclonal light-chain amyloid fibrils. Biochem J 275:67-73.
30. Norling B, Westermark GT, and Westermark P (1988). Immunohistochemical identification of heparan sulfate proteoglycan in secondary systemic amyloidosis. Clin Exp Immunol 73:333-337.
31. Ohishi H, Skinner M, Sato-Araki N, Okuyama T, Gejyo F, Kimura A, Cohen AS, and Schmid K (1990). Glycosaminoglycans of the hemodialysis-associated carpal synovial amyloid and of amyloid-rich tissues and fibrils of heart, liver, and spleen. Clin Chem 36:88-91.
32. Perlmutter LS, Chui HC, Saperia D, and Athanikar J (1990). Microangiopathy and the colocalization of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimer's disease. Brain Res 508:13-19.
33. Saperia D, Perlmutter LS, Athanikar J, and Chui HC (1988). Amyloid P component in dementia. Soc Neurosci Abstr 14:636.
34. Shirahama T and Cohen AS (1967). High-resolution electron microscopic analysis of the amyloid fibrils. J Cell Biol 33: 679-708.
35. Skinner M and Cohen AS (1976). Aspects of the amyloid P component. In: Wegelius O and Pasternack A, editors. Amyloidosis. New York: Academic Press, 339.
36. Skinner M, Sipe JD, Yood RA, Shirahama T, and Cohen AS (1982). Characterization of P-component (AP) isolated from amyloidotic tissue: Half-life studies of human and murine AP. Ann N Y Acad Sci 389:190-198.
37. Snow AD and Wight TN (1989). Proteoglycans in the pathogenesis of Alzheimer's disease and other amyloidoses. Neurobiol Aging 10:481-497.
38. Snow AD, Bramson R, Mar H, Wight TN, and Kisilevsky R (1991). A temporal and ultrastructural relationship between heparan sulfate proteoglycans and AA amyloid in experimental amyloidosis. J Histochem Cytochem 39:1321-1230.
39. Snow AD, Mar H, Nochlin D, Kimata K, Kato M, Suzuki S, Hassell J, and Wight TN (1988). The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. Am J Pathol 133:456-463.
40. Snow AD, Wight TN, Nochlin D, Koike Y, Kimata K, DeArmond SJ, and Prusiner SB (1990). Immunolocalization of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann-Straussler syndrome, Creutzfeldt-Jakob disease and scrapie. Lab Invest 63:601-611.
41. Snow AD, Willmer J, and Kisilevsky R (1987). A close ultrastructural relationship between sulfated proteoglycans and AA amyloid fibrils. Lab Invest 57:687-698.
42. Sorensen GD and Finke E (1968). The ultrastructure of amyloid. In: Mandema E, Ruinen L, Scholten JH, and Cohen AS, editors. Amyloidosis: Proceedings of the Symposium of Amyloidosis, University of Groningen, The Netherlands. Amsterdam: Excerpta Medica Foundation, 184.
43. Stenstad T, Magnus JH, Kolset SO, and Husby G (1991). Identification of glucosaminoglycans in human renal and splenic secondary AA amyloid fibril preparations. Scand J Rheumatol 20:1-7.
44. Terry RD, Gonatas NK, and Weiss M (1964). Ultrastructural studies in Alzheimer's presenile dementia. Am J Pathol 44:269-297.
45. Young ID, Willmer JP, and Kisilevsky R (1989). The ultrastructural localization of sulfated proteoglycans is identical in the amyloids of Alzheimer's disease and AA, AL, senile cardiac and medullary carcinoma-associated amyloidosis. Acta Neuropathol 78:202-209.